Additionally, EP2 silencing reduces proliferation and invasion by decreasing the expression of matrix metallopeptidases 2 and 9 (MMP2 and MMP9), and cyclin D; conversely, EP2 overexpression increases tumor volume and metastasis by activating MMPs (60). Here, PTGER2 is linked to neoplasm.